Literature DB >> 1428778

The role of free radicals as mediators of endothelial cell injury in hyperhomocysteinemia.

R Clarke1, E Naughten, S Cahalane, K O Sullivan, P Mathias, T McCall, I Graham.   

Abstract

Hyperhomocysteinemia has been suggested as a potent new risk factor for premature cardiovascular disease. Homocsyteine can induce endothelial cell injury but the mechanism is not understood. The purpose of this study was to evaluate the role of free radicals as potential causes of endothelial cell injury in a case-control study of obligate heterozygotes for cystathionine beta-synthase deficiency. Firstly, free radical production as measured by neutrophil chemiluminescence in obligate heterozygotes for cystathionine beta-synthase deficiency was compared with age- and sex-matched normal subjects. Secondly, the response of the cellular antioxidant system was examined by measuring the enzymes superoxide dismutase and glutathione peroxidase, their cofactors (selenium, copper), vitamin E and vitamin A in heterozygotes and normal subjects. Analyses of neutrophil chemiluminescence, vitamin A and E, glutathione peroxidase, selenium and copper showed no difference between heterozygotes and controls. While superoxide dismutase activity was higher in heterozygotes than normal subjects, the difference did not reach statistical significance and the hypothesis of excess free radical production as a mechanism of injury was not confirmed. However, further examination of superoxide dismutase activity in a larger number of subjects would be of interest.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1428778     DOI: 10.1007/bf02940559

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  27 in total

Review 1.  Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function.

Authors:  S Moncada; M W Radomski; R M Palmer
Journal:  Biochem Pharmacol       Date:  1988-07-01       Impact factor: 5.858

2.  Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease.

Authors:  S S Kang; P W Wong; H Y Cook; M Norusis; J V Messer
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

3.  Moderate homocysteinemia--a possible risk factor for arteriosclerotic cerebrovascular disease.

Authors:  L E Brattstrom; J E Hardebo; B L Hultberg
Journal:  Stroke       Date:  1984 Nov-Dec       Impact factor: 7.914

4.  Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase.

Authors:  D E Paglia; W N Valentine
Journal:  J Lab Clin Med       Date:  1967-07

5.  Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion.

Authors:  T B McCall; N K Boughton-Smith; R M Palmer; B J Whittle; S Moncada
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

6.  Simultaneous determination of alpha-tocopherol and retinol in plasma or red cells by high pressure liquid chromatography.

Authors:  J G Bieri; T J Tolliver; G L Catignani
Journal:  Am J Clin Nutr       Date:  1979-10       Impact factor: 7.045

7.  The production of free radicals during the autoxidation of cysteine and their effect on isolated rat hepatocytes.

Authors:  G Saez; P J Thornalley; H A Hill; R Hems; J V Bannister
Journal:  Biochim Biophys Acta       Date:  1982-10-28

8.  Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine.

Authors:  G Starkebaum; J M Harlan
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

9.  Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor.

Authors:  S Parthasarathy
Journal:  Biochim Biophys Acta       Date:  1987-02-14

10.  The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levels.

Authors:  W S Stryker; L A Kaplan; E A Stein; M J Stampfer; A Sober; W C Willett
Journal:  Am J Epidemiol       Date:  1988-02       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.